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Background: Cartilage destruction in osteoarthritis (OA) involves 
excessive degradation and increased synthesis of cartilage ma- 
trix macromolecules including type II collagen and proteoglycans. 
Cartilage biomarkers exist for the measurement of changes in 
cartilage matrix turnover. 
Aim: To determine whether there is a relationship between serum 
levels of type II collagen degradation and synthesis biomarkers 
(C2C, C1,2C and CP II) and radiological data in patients with hip 
OA and generalized OA. 
Patients and methods: 56 patients (mean age/SD: 62/11; 
BMI/SD: 27/11) with symptomatic hip OA (Lequesne index/SD: 
8.3/4.). Minimum joint space width (Min JSW) was obtained by 
computer measurement. The following serum markers were stud- 
ied using commercial kits from Ibex Diagnostics (Montreal, QC): 
type II collagen synthesis C-propeptide (CPII), cleavage by col- 
lagenase of type II (C2C) and types I and II (C1, 2C) collagens. 
The other studied variables were: age, sex, BMI, hip OA bilater- 
ality, and the number of involved joints. Patients with OA affecting 
more than 3 different joints were classified has having general- 
ized OA (GOA). 
Statistics: Multivariate analysis 
Results Unilateral hip OA without any other joint involvement was 
observed in 17 patients.Twenty two patients had bilateral hip OA 
and 24 GOA. MinJSW was 2.234-1.25 mm. 
There was a correlation between min JSW and C2C in patients 
with unilateral hip OA (R=0.50, p= 0.02). 
CPII levels were significantly lower in patients with GOA 
(99.94-50.3ng/mL versus 141.94-81.2ng/mL, p=0.04, OR= 0.18 
for CPII >120 ng/mL, [CI-95% 0.05-0.6], p<0.005). 
Conclusion: Differences in the pathogenesis of hip OA can 
be distinguished by systemic measurement of certain cartilage 
biomarkers. Generalized OA may be due to a deficiency in a 
reparative process involving type II collagen. The significant cor- 
relation between C2C and JSW in unilateral hip OA suggests that 
this marker is of value in assessing cartilage degradation in pa- 
tients with involvement of a single hip joint. 
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Purpose: Matrix metalloproteinases cleave the Type II collagen 
helix into 3/4- and 1/4-length fragments. Urinary levels of neoepi- 
topes on the larger fragment (uTIINE)have been shown to dif- 
ferentiate symptomatic OA from asymptomatic disease. This pi- 
lot study asked whether (a) baseline uTIINE levels predict radio- 
graphic and symptomatic progression of knee OA and (b) serial 
values reflect concurrent JSN. 
Methods: Subjects were 120 women with unilateral knee OA who 
completed a 30-mo RCT of structure-modification by doxycycline 
(doxy). Sixty were x-ray progressors (mean JSN 4- SD = 0.97 4- 
0.75 mm); 60 were non-progressors (-0.03 4- 0.17 mm). 
Each group contained 30 subjects who exhibited clinically signif- 
icant increases in knee pain over 30 mos and 30 who did not. 
Urine samples were collected every 6 mos for analysis of uTI- 
INE with an antibody capture assay that measured the levels of 
a 45-mer peptide resulting from collagenase cleavage of Type II 
collagen, uTIINE values were normalized for urinary creatinine 
(Cr). 
Results: Results of logistic regression analyses to predict JSN 
and knee pain are shown in Table 1. In the placebo group, uTI- 
INE was unrelated to JSN or knee pain. However, in the doxy 
group, a 1-SD increment in baseline uTIINE (68 ng/mM Cr) was 
associated with a 2-fold increase in odds of progression of JSN 
(OR 2.04, P=0.058). 
Table 1. Prediction of JSN and Knee Pain 
Outcome Placebo Group (N = 69) 
uTIINE SD = 64 ng/mM Cr 
Doxy Group (N = 51) 
uTIINE SD = 68 ng/mM Cr 
Odds Ratio* 95% CI Odds Ratio* 95% CI 
JSN 0.74 0.44 - 1.23 2.04 0.98 - 4.28 
Knee Pain 0.71 0.41 - 1.23 0.80 0.43 - 1.50 
*Change in odds of progression of JSN per 1-SD increase in the baseline 
uTIINE concentration, adjusted for baseline JSW and baseline VAS score 
for 50-ft Walk Pain. Odds ratios for prediction of knee pain were adjusted 
also for baseline BMI. 
In an analysis of JSN over discrete time intervals, mixed mod- 
els showed that both the mean and maximum of the intercurrent 
uTIINE values were associated with JSN (Table 2). 
Table 2. Concurrent Association Between uTIINE and JSN 
Intercurrent uTIINE 0-16 Month Interval 16-30 Month Interval 
SD of Parameter SD of Parameter 
uTIINE Estimate* uTIINE Estimate* 
Mean 69 0.10~: 66 0.17~:§ 
Maximum 108 0.14~: 98 0.101 
*Parameter Estimate = change in JSN, in mm, associated with a 1-SD in- 
crease in mean or maximum uTIINE concentration (ng/mM Cr) after adjust- 
ment for age, knee and JSW at the start of the interval, tP<0.05; ~:P<0.01 ; § 
A significant uTIINE by Treatment Group interaction was detected (P<0.05). 
The data shown represent he association between mean uTIINE levels and 
JSN in the placebo group only. 
Conclusion: uTIINE was not a consistent predictor of JSN or 
knee pain in subjects with knee OA. However, serial uTIINE val- 
ues reflected concurrent JSN. 
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Study Aims: To evaluate whether baseline levels of interleukin 
(IL)-I, IL-6 or tumor necrosis factor (TNF)-~ are associated with 
